Literature DB >> 25458990

The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

John Chan1, Simren Mehta2, Sushma Bharrhan2, Yong Chen2, Jacqueline M Achkar3, Arturo Casadevall2, JoAnne Flynn4.   

Abstract

Mycobacterium tuberculosis remains a major public health burden. It is generally thought that while B cell- and antibody-mediated immunity plays an important role in host defense against extracellular pathogens, the primary control of intracellular microbes derives from cellular immune mechanisms. Studies on the immune regulatory mechanisms during infection with M. tuberculosis, a facultative intracellular organism, has established the importance of cell-mediated immunity in host defense during tuberculous infection. Emerging evidence suggest a role for B cell and humoral immunity in the control of intracellular pathogens, including obligatory species, through interactions with the cell-mediated immune compartment. Recent studies have shown that B cells and antibodies can significantly impact on the development of immune responses to the tubercle bacillus. In this review, we present experimental evidence supporting the notion that the importance of humoral and cellular immunity in host defense may not be entirely determined by the niche of the pathogen. A comprehensive approach that examines both humoral and cellular immunity could lead to better understanding of the immune response to M. tuberculosis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; B cells; FcγR; Mycobacterium tuberculosis; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25458990      PMCID: PMC4314354          DOI: 10.1016/j.smim.2014.10.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  238 in total

1.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 2.  The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.

Authors:  Aharona Glatman-Freedman
Journal:  Tuberculosis (Edinb)       Date:  2006-04-03       Impact factor: 3.131

3.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

4.  Elie Metchnikoff's and Paul Ehrlich's impact on infection biology.

Authors:  Stefan H E Kaufmann
Journal:  Microbes Infect       Date:  2008-09-12       Impact factor: 2.700

5.  Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.

Authors:  A E Platonov; E J Kuijper; I V Vershinina; G A Shipulin; N Westerdaal; C A Fijen; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection.

Authors:  J Scott Hale; Ben Youngblood; Donald R Latner; Ata Ur Rasheed Mohammed; Lilin Ye; Rama S Akondy; Tuoqi Wu; Smita S Iyer; Rafi Ahmed
Journal:  Immunity       Date:  2013-04-11       Impact factor: 31.745

7.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

8.  Requirement of B cells for generating CD4+ T cell memory.

Authors:  Jason K Whitmire; Mary S Asano; Susan M Kaech; Surojit Sarkar; Lynn G Hannum; Mark J Shlomchik; Rafi Ahmed
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 9.  Accelerating next-generation vaccine development for global disease prevention.

Authors:  Wayne C Koff; Dennis R Burton; Philip R Johnson; Bruce D Walker; Charles R King; Gary J Nabel; Rafi Ahmed; Maharaj K Bhan; Stanley A Plotkin
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

10.  Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Yasuyo Shimomura; Kiyotaka Nagahama; Atsushi Mizoguchi; Atul K Bhan
Journal:  Gastroenterology       Date:  2007-04-14       Impact factor: 22.682

View more
  50 in total

Review 1.  Tuberculosis in Children.

Authors:  Tania A Thomas
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

2.  Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Authors:  Markus Maeurer; Martin Rao; Alimuddin Zumla
Journal:  Ann Transl Med       Date:  2015-05

3.  Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection.

Authors:  Sambasivan Venkatasubramanian; Deepak Tripathi; Torry Tucker; Padmaja Paidipally; Satyanarayana Cheekatla; Elwyn Welch; Anjana Raghunath; Ann Jeffers; Amy R Tvinnereim; Melissa E Schechter; Bruno B Andrade; Nizel Mackman; Steven Idell; Ramakrishna Vankayalapati
Journal:  Eur J Immunol       Date:  2015-11-10       Impact factor: 5.532

4.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

5.  Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.

Authors:  Joel D Ernst
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 6.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

Review 7.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 8.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

9.  Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents.

Authors:  Christiane M Schmidt; Kathryn L Lovero; Fabiana R Carvalho; Daniele C M Dos Santos; Ana Cláudia M W Barros; Ana Paula Quintanilha; Ana Paula Barbosa; Marcos V S Pone; Sheila M Pone; Julienne Martins Araujo; Camila de Paula Martins; Solange G D Macedo; Ana Lúcia Miceli; Maria Luíza Vieira; Selma M A Sias; Adriano Queiroz; Luis Guillermo Coca Velarde; Afranio L Kritski; Andrea A Silva; Clemax C Sant'Anna; Lee W Riley; Claudete A Araújo Cardoso
Journal:  Tuberculosis (Edinb)       Date:  2019-12-05       Impact factor: 3.131

10.  Serological biomarkers for monitoring response to treatment of pulmonary and extrapulmonary tuberculosis in children and adolescents.

Authors:  Danielle C M Dos Santos; Kathryn L Lovero; Christiane M Schmidt; Ana Cláudia M W Barros; Ana Paula Quintanilha; Ana Paula Barbosa; Marcos V S Pone; Sheila M Pone; Julienne Martins Araujo; Camila de Paula Martins; Estela Magalhães Cosme; Thais Raquelly Dourado de Oliveira; Ana Lúcia Miceli; Maria Luíza Vieira; Adriano Queiroz; Luis Guillermo Coca Velarde; Afranio Kritski; Maria de Fátima Pombo March; Selma Maria de Azevedo Sias; Clemax C SantÀAnna; Lee W Riley; Claudete A Araújo Cardoso
Journal:  Tuberculosis (Edinb)       Date:  2020-06-26       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.